Blood thinners in pregnancy with mechanical heart valves
Part of Blood & lymphatic, Heart & circulation, Women’s health & pregnancy clinical trials.
This study looks at the best way to manage blood thinners for pregnant people who have mechanical heart valves. It aims to find the safest approach for both the mother and the baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are pregnant with one or more mechanical heart valves.
- You are 18 years or older.
- You are less than 12 weeks pregnant.
- You are willing to participate in the study.
- You do not have a very low platelet count (less than 50 x 10^9/L).
- You do not have active bleeding causing significant blood loss or unstable blood pressure.
- You do not have a new valve blood clot right before pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at pregnancy-related risk for a dangerous blood clot in the leg or lung (venous thromboembolism). It focuses on pregnant people who already have a higher-than-average risk and wants to see how to manage that risk safely.
This study looks at how pregnancy affects blood clots in healthy women. If you qualify, researchers will check your blood's clotting properties to learn more about pregnancy-related changes.
This study looks at the best way to manage blood thinners (like injections of LMWH) during pregnancy for people who need them because of a past or current blood clot risk. It may help by improving how safely and effectively anticoagulation is handled to reduce clot complications.
This study looks at how blood clotting changes during pregnancy and how a common blood thinner affects clotting in the lab. It may help doctors understand pregnancy-related clotting risks better.
This study compares the best way to give blood thinners around certain heart procedures (TEER or left atrial appendage closure). It aims to lower the risk of dangerous clots and bleeding during and after the procedure.
This study looks at how people’s blood and clotting behave during pregnancy when taking a specific blood thinner called low molecular weight heparin (LMWH) three times a day. It may help doctors fine-tune how safely and effectively LMWH is used during pregnancy.
Hear when a new Pregnancy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.